A site-specific controlled-release system for metformin

Journal of Pharmacy and Pharmacology

Volumn 57, Issue 5, 2005, Pages 565-571

  Di Colo, Giacomo ^a   Zambito, Ylenia ^a   Baggiani, Andrea ^a   Carelli, Vera ^a   Serafini, Maria Francesca ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIGUANIDE DERIVATIVE; EUDRAGIT; GLYCEROL PALMITOSTEARATE; METFORMIN; ORAL ANTIDIABETIC AGENT; POLYMER;

ARTICLE; CALCULATION; COMPRESSION; CONTROLLED DRUG RELEASE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG COATING; DRUG DIFFUSION; DRUG FORMULATION; DRUG SOLUBILITY; HYDRODYNAMICS; ILEUM; INTESTINE ABSORPTION; INTESTINE FLUID; JEJUNUM; KINETICS; PARTICLE SIZE; PH; PHARMACOKINETICS; POROSITY; SIMULATION; STOMACH JUICE; SUSTAINED RELEASE PREPARATION; TECHNIQUE;

BIOLOGICAL AVAILABILITY; DRUG COMPOUNDING; HUMANS; HYPOGLYCEMIC AGENTS; ILEUM; JEJUNUM; KINETICS; METFORMIN; MODELS, BIOLOGICAL; ORGAN SPECIFICITY; SOLUBILITY; STOMACH; TABLETS, ENTERIC-COATED;

EID: 17644388050     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357056037     Document Type: Article

References (21)

1. Carelli, V., Di Colo, G., Nannipieri, E., Poli, B., Serafini, M. F. (2000) Polyoxyethylene poly(methacrylic acid-comethyl methacrylate) compounds for site-specific peroral delivery. Int. J. Pharm. 202: 103-112
2. Davis, S. S., Wilding, E. A., Wilding, I. R (1993) Gastrointestinal transit of a matrix tablet formulation: comparison of canine and human data. Int. J. Pharm. 94: 235-238
3. Desai, S. J., Simonelli, A. P., Higuchi, W. I. (1965) Investigation of factors influencing release of solid drug dispersed in inert matrices. J. Pharm. Sci. 54: 1459-1464
4. Di Colo, G., Falchi, S., Zambito, Y. (2002) In vitro evaluation of a system for pH-controlled peroral delivery of metformin. J. Control. Release 80: 119-128
5. Flynn, G. L., Yalkowsky, S. H., Roseman, T. J. (1974) Mass transport phenomena and models: theoretical concepts. J. Pharm. Sci. 63: 479-509
6. Gusler, G., Gorsline, J., Levy, G., Zhang, S. Z., Weston, I. E., Naret, D., Berner, B. (2001) Pharmacokinetics of metformin gastric-retentive tablets in healthy volunteers. J. Clin. Pharmacol. 41: 655-661
7. Hamdani, J., Moës, A. J., Amighi, K. (2003) Physical and thermal characterisation of Precirol and Compritol as lipophilic glycerides used for the preparation of controlled-release matrix pellets. Int. J. Pharm. 260: 47-57
8. Higuchi, T. (1963) Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J. Pharm. Sci. 52: 1145-1149
9. Karttunen, P., Uusitupa, M., Lamminsivu, U. (1983) The pharmacokinetics of metformin: a comparison of the properties of a rapid-release and a sustained release preparation. Int. J. Clin. Pharmacol. Ther. Toxicol. 21: 31-36
10. Marchetti, P., Navalesi, R. (1989) Pharmacokinetic-pharmacodynamic relationships of oral hypoglycaemic agents. An update. Clin. Pharmacokinet. 16: 100-128
11. Noel, M. (1980) Kinetic study of normal and sustained dosage forms of metformin in normal subjects. J. Int. Biomed. Info. Data 1: 9-20
12. Obaidat, A. A., Obaidat, R. M. (2001) Controlled release of tramadol hydrochloride from matrices prepared using glyceryl behenate. Eur. J. Pharm. Biopharm. 52: 231-235
13. Pentikainen, P. J. (1986) Bioavailability of metformin. Comparison of solution, rapidly dissolving tablet, and three sustained release products. Int. J. Clin. Pharmacol. Ther. Toxicol. 24: 213-220
14. Saraiya, D., Bolton, S. (1990) The use of Precirol to prepare sustained release tablets of theophylline and quinidine gluconate. Drug Dev. Ind. Pharm. 16: 1963-1969
15. Scheen, A. J. (1996) Clinical pharmacokinetics of metformin. Clin. Pharmacokinet. 30: 359-371
16. Stepensky, D., Friedman, M., Srour, W., Raz, I., Hoffman, A. (2001) Preclinical evaluation of pharmacokinetic-pharmacodynamic rationale for oral CR metformin formulation. J. Control. Release 71: 107-115
17. Thomsen, L. J., Schaefer, T., Kristensen, H. G. (1994) Prolonged release matrix pellets prepared by melt pelletization. II. Hydrophobic substances as meltable binders. Drug Dev. Ind. Pharm. 20: 1179-1197
18. Vidon, N., Chaussade, S., Noel, M., Franchisseur, C., Huchet, B., Bernier, J. J. (1988) Metformin in the digestive tract. Diabetes Res. Clin. Pract. 4: 223-229
19. Zambito, Y., Di Colo, G. (2003) Preparation and in vitro evaluation of chitosan matrices for colonic controlled drug delivery. J. Pharm. Pharm. Sci. 6: 274-281
20. Zhang, Y. E., Schwartz, B. (2003) Melt granulation and heat treatment for wax matrix-controlled drug release. Drug Dev. Ind. Pharm. 29: 131-138
21. Zhang, Y. E., Tchao, R., Schwartz, J. B. (2001) Effect of processing methods and heat treatment on the formation of wax matrix tablets for sustained drug release. Pharm. Dev. Technol. 6: 131-144